Last CNY15.09 CNY
Change Today +0.36 / 2.44%
Volume 8.8M
002566 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

jilin jian yisheng pharmac-a (002566) Snapshot

Open
CNY14.69
Previous Close
CNY14.73
Day High
CNY15.25
Day Low
CNY14.61
52 Week High
10/9/14 - CNY17.23
52 Week Low
03/28/14 - CNY12.51
Market Cap
5.0B
Average Volume 10 Days
4.5M
EPS TTM
CNY0.27
Shares Outstanding
331.0M
EX-Date
05/22/14
P/E TM
56.6x
Dividend
CNY0.07
Dividend Yield
0.44%
Current Stock Chart for JILIN JIAN YISHENG PHARMAC-A (002566)

Related News

No related news articles were found.

jilin jian yisheng pharmac-a (002566) Related Businessweek News

No Related Businessweek News Found

jilin jian yisheng pharmac-a (002566) Details

Jilin Jian Yisheng Pharmaceutical Co., Ltd. engages in the research, development, production, and distribution of Chinese patent drugs for the treatment of cardiovascular and cerebrovascular diseases. Its principal products include Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections, and Guifu Dihuang capsules. The company offers drug class products covering medicine to protect species, non-prescription drugs, essential drugs, and others; participation products, such as Moods and Zhenyuan capsules, as well as Ginseng resorcinol compound liniments; and Bee class products consisting of Honey, a nutritious food; Propolis, a natural immune enhancer; Royal jelly, a royal jelly ingredient; Pollen, a high-protein low-fat nutrition; and Gift Series products. Its products are also used for respiratory, alimentary, endocrine, and urinary system diseases; tumors and paediatric diseases; and others. The company is based in Ji'an, China.

jilin jian yisheng pharmac-a (002566) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jilin jian yisheng pharmac-a (002566) Key Developments

Jilin Jian Yisheng Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Feb 10, 2015

Jilin Jian Yisheng Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Feb 10, 2015., at 14:00 China Standard Time. Agenda: To consider the application for working capital loan to banks.

Jilin Jian Yisheng Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Dec 23, 2014

Jilin Jian Yisheng Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Dec 23, 2014., at 14:00 China Standard Time. Agenda: To consider the repayment of bank loan and permanent replenishment of working capital with surplus fund from projects invested with raised proceeds, partial excessive raised funds and interests accrued.

Jilin Jian Yisheng Pharmaceutical Co., Ltd. Amends its Articles of Association

Jilin Jian Yisheng Pharmaceutical Co., Ltd. announced that at the Extraordinary General Meeting of the company held on November 12, 2014, the company approved amendments to its articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002566:CH CNY15.09 CNY +0.36

002566 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002566.
View Industry Companies
 

Industry Analysis

002566

Industry Average

Valuation 002566 Industry Range
Price/Earnings 51.2x
Price/Sales 5.8x
Price/Book 2.8x
Price/Cash Flow 51.2x
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JILIN JIAN YISHENG PHARMAC-A, please visit www.yisheng-pharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.